Cindy Wen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cindy Wen has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Michael J. Gandal
University of Pennsylvania
5 shared publications - Chunyu Liu
Department of Psychiatry, SUNY Upstate Medical University, Syracuse, USA
4 shared publications - Arjun Bhattacharya
Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, USA
3 shared publications - Cuihua Xia
Central South University
3 shared publications - Daniel H. Geschwind
UCLA
3 shared publications David Parker
Departments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, USA
3 shared publications
Latest Publications
- Open Access
- 29 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Leveraging genomic and transcriptomic data of diverse ancestry to uncover mechanisms of psychiatric risk in the adult and developing brain
We explore strategies to harness ancestral diversity in PsychENCODE Consortium Genotype-Expression (GEx) reference panels (adult and developing brain) and Psychiatric Genomics Consortium GWAS data to improve genetically regulated expression (GReX) models and their use for Transcriptome-wide association study (TWAS) discoveries, uncovering previously unknown aspects of psychiatric functional genomics. We trained multiple GReX models on rigorously constructed GEx panel subsets, generated by downsampling, segregating, and/or mixing samples of Admixed African and European ancestries, and based on disease status. Ancestry-specific GReX genes were enriched in pathways involving mitochondrial functions, organelle structure, and metabolism. These models were integrated with ancestry-specific GWASs to conduct bipolar disorder, major depressive disorder, posttraumatic stress disorder, and schizophrenia TWAS. TWAS signals obtained by applying AA- and EUR-specific GReX models to an ancestry-specific GWAS were largely concordant, and mismatched-TWAS (e.g. AA-GReX applied to EUR-GWAS) revealed biologically meaningful signals missed by matched-TWAS. Shared signals across the four disorders were more prominent in the developing brain, involving genes such as H4C13, ZSCAN12P1, and FLOT1, and pathways related to megakaryocyte and muscle development, and neurotransmitter regulation. Overall, we demonstrate concordance in shared TWAS signals across GReX models and provide insight into GReX-specific detectable genes and pathways.
- 29 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessLeveraging genomic and transcriptomic data of diverse ancestry to uncover mechanisms of psychiatric risk in the adult and developing brain
We explore strategies to harness ancestral diversity in PsychENCODE Consortium Genotype-Expression (GEx) reference panels (adult and developing brain) and Psychiatric Genomics Consortium GWAS data to improve genetically regulated expression (GReX) models and their use for Transcriptome-wide association study (TWAS) discoveries, uncovering previously unknown aspects of psychiatric functional genomics. We trained multiple GReX models on rigorously constructed GEx panel subsets, generated by downsampling, segregating, and/or mixing samples of Admixed African and European ancestries, and based on disease status. Ancestry-specific GReX genes were enriched in pathways involving mitochondrial functions, organelle structure, and metabolism. These models were integrated with ancestry-specific GWASs to conduct bipolar disorder, major depressive disorder, posttraumatic stress disorder, and schizophrenia TWAS. TWAS signals obtained by applying AA- and EUR-specific GReX models to an ancestry-specific GWAS were largely concordant, and mismatched-TWAS (e.g. AA-GReX applied to EUR-GWAS) revealed biologically meaningful signals missed by matched-TWAS. Shared signals across the four disorders were more prominent in the developing brain, involving genes such as H4C13, ZSCAN12P1, and FLOT1, and pathways related to megakaryocyte and muscle development, and neurotransmitter regulation. Overall, we demonstrate concordance in shared TWAS signals across GReX models and provide insight into GReX-specific detectable genes and pathways.
- Open Access
- 20 February 2025
- Published by Springer Nature in Research Square
Leveraging genomic and transcriptomic data of diverse ancestry to uncover mechanisms of psychiatric risk in the adult and developing brain
To better understand molecular mechanisms underlying psychiatric disorders, we need improved analytic approaches for integrating large-scale genomic data with brain-based transcriptomics. However, one critical component of individual variation - different levels of gene regulation due to genetic ancestry diversity - has not been traditionally incorporated into such analyses. To address this, we leveraged the ancestral diversity of individuals in adult and developing brain Genotype-Expression (GEx) reference panels of the PsychENCODE Project and psychiatric GWAS of the Psychiatric Genomics Consortium to enhance detection of GReX (Genetically Regulated gene expression) and transcriptome-wide association study (TWAS) signals. To investigate alternative GEx-level choices, we trained GReX models using rigorously constructed subsets of the human postmortem dorsolateral prefrontal cortex GEx panel, generated through downsampling, segregating, and mixing samples of Admixed African (AA) and European (EUR) ancestries, while considering disease status in the subset design. TWAS-based gene trait associations (GTAs) were obtained by integrating these GReX models with ancestry-specific GWASs of bipolar disorder (BIP), major depressive disorder (MDD), post-traumatic stress disorder (PTSD) and schizophrenia (SCZ). Genes with ancestry-specific GReX were enriched in specialized pathways involving mitochondrial functions, organelle structure, and metabolism, while genes with GReX in both ancestries demonstrated high concordance (>95%) in predictor SNP weight directions. Applying GReX from either ancestry to a single ancestry GWAS produced GTAs with concordant effects sizes while each uncovering unique FDR significant trait associated signals at the gene and pathway levels. GTAs based on AA GWAS meta analyzed with GTAs based on EUR GWAS enhanced signals and alleviated noise. EUR-specific GReX produced TWAS pathways that included corticosteroid signaling in PTSD, TGF-beta and neurotrophins in MDD, and inflammation and viral life cycle in SCZ. AA-specific GReX produced TWAS pathways that included glutamine signaling in PTSD, proline-peptide DNA activity in MDD, and immune cytotoxicity, serotoninergic and dopaminergic pathways in SCZ. Genes with ancestry-specific GReX in adult and developing brain were part of similar pathways. Finally, the developing brain TWAS were enriched in specialized developmental and neuronal pathways and produced a higher proportion of shared signals between ancestries. In conclusion, we demonstrate the benefits of leveraging diverse ancestral backgrounds in TWAS analysis, provide insights into which genes and pathways are better captured by ancestry-specific panels, and advocate for genomic region-specific TWAS integration strategies over a uniform genome-wide approach to uncover molecular mechanisms.
- 20 February 2025
- Published by Springer Nature in Research Square
Open AccessLeveraging genomic and transcriptomic data of diverse ancestry to uncover mechanisms of psychiatric risk in the adult and developing brain
To better understand molecular mechanisms underlying psychiatric disorders, we need improved analytic approaches for integrating large-scale genomic data with brain-based transcriptomics. However, one critical component of individual variation - different levels of gene regulation due to genetic ancestry diversity - has not been traditionally incorporated into such analyses. To address this, we leveraged the ancestral diversity of individuals in adult and developing brain Genotype-Expression (GEx) reference panels of the PsychENCODE Project and psychiatric GWAS of the Psychiatric Genomics Consortium to enhance detection of GReX (Genetically Regulated gene expression) and transcriptome-wide association study (TWAS) signals. To investigate alternative GEx-level choices, we trained GReX models using rigorously constructed subsets of the human postmortem dorsolateral prefrontal cortex GEx panel, generated through downsampling, segregating, and mixing samples of Admixed African (AA) and European (EUR) ancestries, while considering disease status in the subset design. TWAS-based gene trait associations (GTAs) were obtained by integrating these GReX models with ancestry-specific GWASs of bipolar disorder (BIP), major depressive disorder (MDD), post-traumatic stress disorder (PTSD) and schizophrenia (SCZ). Genes with ancestry-specific GReX were enriched in specialized pathways involving mitochondrial functions, organelle structure, and metabolism, while genes with GReX in both ancestries demonstrated high concordance (>95%) in predictor SNP weight directions. Applying GReX from either ancestry to a single ancestry GWAS produced GTAs with concordant effects sizes while each uncovering unique FDR significant trait associated signals at the gene and pathway levels. GTAs based on AA GWAS meta analyzed with GTAs based on EUR GWAS enhanced signals and alleviated noise. EUR-specific GReX produced TWAS pathways that included corticosteroid signaling in PTSD, TGF-beta and neurotrophins in MDD, and inflammation and viral life cycle in SCZ. AA-specific GReX produced TWAS pathways that included glutamine signaling in PTSD, proline-peptide DNA activity in MDD, and immune cytotoxicity, serotoninergic and dopaminergic pathways in SCZ. Genes with ancestry-specific GReX in adult and developing brain were part of similar pathways. Finally, the developing brain TWAS were enriched in specialized developmental and neuronal pathways and produced a higher proportion of shared signals between ancestries. In conclusion, we demonstrate the benefits of leveraging diverse ancestral backgrounds in TWAS analysis, provide insights into which genes and pathways are better captured by ancestry-specific panels, and advocate for genomic region-specific TWAS integration strategies over a uniform genome-wide approach to uncover molecular mechanisms.
- 21 December 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (6) , 2673-2685
Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk and unique genomic associations
The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) created psychosis Biotypes based on neurobiological measurements in a multi-ancestry sample. These Biotypes cut across DSM diagnoses of schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis. Two recently developed post hoc ancestry adjustment methods of Polygenic Risk Scores (PRSs) generate Ancestry-Adjusted PRSs (AAPRSs), which allow for PRS analysis of multi-ancestry samples. Applied to schizophrenia PRS, we found the Khera AAPRS method to show superior portability and comparable prediction accuracy as compared with the Ge method. The three Biotypes of psychosis disorders had similar AAPRSs across ancestries. In genomic analysis of Biotypes, 12 genes, and isoforms showed significant genomic associations with specific Biotypes in a Transcriptome-Wide Association Study (TWAS) of genetically regulated expression (GReX) in the adult brain and fetal brain. TWAS inflation was addressed by the inclusion of genotype principal components in the association analyses. Seven of these 12 genes/isoforms satisfied Mendelian Randomization (MR) criteria for putative causality, including four genes TMEM140, ARTN, C1orf115, CYREN, and three transcripts ENSG00000272941, ENSG00000257176, ENSG00000287733. These genes are enriched in the biological pathways of Rearranged during Transfection (RET) signaling, Neural Cell Adhesion Molecule 1 (NCAM1) interactions, and NCAM signaling for neurite out-growth. The specific associations with Biotypes suggest that pharmacological clinical trials and biological investigations might benefit from analyzing Biotypes separately.
- 21 December 2024
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (6) , 2673-2685
Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk and unique genomic associations
The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) created psychosis Biotypes based on neurobiological measurements in a multi-ancestry sample. These Biotypes cut across DSM diagnoses of schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis. Two recently developed post hoc ancestry adjustment methods of Polygenic Risk Scores (PRSs) generate Ancestry-Adjusted PRSs (AAPRSs), which allow for PRS analysis of multi-ancestry samples. Applied to schizophrenia PRS, we found the Khera AAPRS method to show superior portability and comparable prediction accuracy as compared with the Ge method. The three Biotypes of psychosis disorders had similar AAPRSs across ancestries. In genomic analysis of Biotypes, 12 genes, and isoforms showed significant genomic associations with specific Biotypes in a Transcriptome-Wide Association Study (TWAS) of genetically regulated expression (GReX) in the adult brain and fetal brain. TWAS inflation was addressed by the inclusion of genotype principal components in the association analyses. Seven of these 12 genes/isoforms satisfied Mendelian Randomization (MR) criteria for putative causality, including four genes TMEM140, ARTN, C1orf115, CYREN, and three transcripts ENSG00000272941, ENSG00000257176, ENSG00000287733. These genes are enriched in the biological pathways of Rearranged during Transfection (RET) signaling, Neural Cell Adhesion Molecule 1 (NCAM1) interactions, and NCAM signaling for neurite out-growth. The specific associations with Biotypes suggest that pharmacological clinical trials and biological investigations might benefit from analyzing Biotypes separately.
- Open Access
Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations
The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) created psychosis Biotypes based on neurobiological measurements in a multi-ancestry sample. These Biotypes cut across DSM diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder with psychosis. Two recently developed post hoc ancestry adjustment methods of Polygenic Risk Scores (PRSs) generate Ancestry-Adjusted PRSs (AAPRSs), which allow for PRS analysis of multi-ancestry samples. Applied to schizophrenia PRS, we found the Khera AAPRS method to show superior portability and comparable prediction accuracy as compared with the Ge method. The three Biotypes of psychosis disorders had similar AAPRSs across ancestries. In genomic analysis of Biotypes, 12 genes and isoforms showed significant genomic associations with specific Biotypes in Transcriptome-Wide Association Study (TWAS) of genetically regulated expression (GReX) in adult brain and fetal brain. TWAS inflation was addressed by inclusion of genotype principal components in the association analyses. Seven of these 12 genes/isoforms satisfied Mendelian Randomization (MR) criteria for putative causality, including four genes TMEM140 , ARTN , C1orf115 , CYREN , and three transcripts ENSG00000272941, ENSG00000257176, ENSG00000287733. These genes are enriched in the biological pathways of Rearranged during Transfection (RET) signaling, Neural Cell Adhesion Molecule 1 (NCAM1) interactions, and NCAM signaling for neurite out-growth. The specific associations with Biotypes suggest that pharmacological clinical trials and biological investigations might benefit from analyzing Biotypes separately.
Open AccessGenetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations
The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) created psychosis Biotypes based on neurobiological measurements in a multi-ancestry sample. These Biotypes cut across DSM diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder with psychosis. Two recently developed post hoc ancestry adjustment methods of Polygenic Risk Scores (PRSs) generate Ancestry-Adjusted PRSs (AAPRSs), which allow for PRS analysis of multi-ancestry samples. Applied to schizophrenia PRS, we found the Khera AAPRS method to show superior portability and comparable prediction accuracy as compared with the Ge method. The three Biotypes of psychosis disorders had similar AAPRSs across ancestries. In genomic analysis of Biotypes, 12 genes and isoforms showed significant genomic associations with specific Biotypes in Transcriptome-Wide Association Study (TWAS) of genetically regulated expression (GReX) in adult brain and fetal brain. TWAS inflation was addressed by inclusion of genotype principal components in the association analyses. Seven of these 12 genes/isoforms satisfied Mendelian Randomization (MR) criteria for putative causality, including four genes TMEM140 , ARTN , C1orf115 , CYREN , and three transcripts ENSG00000272941, ENSG00000257176, ENSG00000287733. These genes are enriched in the biological pathways of Rearranged during Transfection (RET) signaling, Neural Cell Adhesion Molecule 1 (NCAM1) interactions, and NCAM signaling for neurite out-growth. The specific associations with Biotypes suggest that pharmacological clinical trials and biological investigations might benefit from analyzing Biotypes separately.
- Open Access
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (21) , eadn7655
Brain cell-type shifts in Alzheimer’s disease, autism, and schizophrenia interrogated using methylomics and genetics
Few neuropsychiatric disorders have replicable biomarkers, prompting high-resolution and large-scale molecular studies. However, we still lack consensus on a more foundational question: whether quantitative shifts in cell types—the functional unit of life—contribute to neuropsychiatric disorders. Leveraging advances in human brain single-cell methylomics, we deconvolve seven major cell types using bulk DNA methylation profiling across 1270 postmortem brains, including from individuals diagnosed with Alzheimer’s disease, schizophrenia, and autism. We observe and replicate cell-type compositional shifts for Alzheimer’s disease (endothelial cell loss), autism (increased microglia), and schizophrenia (decreased oligodendrocytes), and find age- and sex-related changes. Multiple layers of evidence indicate that endothelial cell loss contributes to Alzheimer’s disease, with comparable effect size to APOE genotype among older people. Genome-wide association identified five genetic loci related to cell-type composition, involving plausible genes for the neurovascular unit ( P2RX5 and TRPV3 ) and excitatory neurons ( DPY30 and MEMO1 ). These results implicate specific cell-type shifts in the pathophysiology of neuropsychiatric disorders.
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (21) , eadn7655
Open AccessBrain cell-type shifts in Alzheimer’s disease, autism, and schizophrenia interrogated using methylomics and genetics
Few neuropsychiatric disorders have replicable biomarkers, prompting high-resolution and large-scale molecular studies. However, we still lack consensus on a more foundational question: whether quantitative shifts in cell types—the functional unit of life—contribute to neuropsychiatric disorders. Leveraging advances in human brain single-cell methylomics, we deconvolve seven major cell types using bulk DNA methylation profiling across 1270 postmortem brains, including from individuals diagnosed with Alzheimer’s disease, schizophrenia, and autism. We observe and replicate cell-type compositional shifts for Alzheimer’s disease (endothelial cell loss), autism (increased microglia), and schizophrenia (decreased oligodendrocytes), and find age- and sex-related changes. Multiple layers of evidence indicate that endothelial cell loss contributes to Alzheimer’s disease, with comparable effect size to APOE genotype among older people. Genome-wide association identified five genetic loci related to cell-type composition, involving plausible genes for the neurovascular unit ( P2RX5 and TRPV3 ) and excitatory neurons ( DPY30 and MEMO1 ). These results implicate specific cell-type shifts in the pathophysiology of neuropsychiatric disorders.
- Open Access
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (21) , eadj4452
Using a comprehensive atlas and predictive models to reveal the complexity and evolution of brain-active regulatory elements
Most genetic variants associated with psychiatric disorders are located in noncoding regions of the genome. To investigate their functional implications, we integrate epigenetic data from the PsychENCODE Consortium and other published sources to construct a comprehensive atlas of candidate brain cis-regulatory elements. Using deep learning, we model these elements’ sequence syntax and predict how binding sites for lineage-specific transcription factors contribute to cell type–specific gene regulation in various types of glia and neurons. The elements’ evolutionary history suggests that new regulatory information in the brain emerges primarily via smaller sequence mutations within conserved mammalian elements rather than entirely new human- or primate-specific sequences. However, primate-specific candidate elements, particularly those active during fetal brain development and in excitatory neurons and astrocytes, are implicated in the heritability of brain-related human traits. Additionally, we introduce PsychSCREEN, a web-based platform offering interactive visualization of PsychENCODE-generated genetic and epigenetic data from diverse brain cell types in individuals with psychiatric disorders and healthy controls.
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (21) , eadj4452
Open AccessUsing a comprehensive atlas and predictive models to reveal the complexity and evolution of brain-active regulatory elements
Most genetic variants associated with psychiatric disorders are located in noncoding regions of the genome. To investigate their functional implications, we integrate epigenetic data from the PsychENCODE Consortium and other published sources to construct a comprehensive atlas of candidate brain cis-regulatory elements. Using deep learning, we model these elements’ sequence syntax and predict how binding sites for lineage-specific transcription factors contribute to cell type–specific gene regulation in various types of glia and neurons. The elements’ evolutionary history suggests that new regulatory information in the brain emerges primarily via smaller sequence mutations within conserved mammalian elements rather than entirely new human- or primate-specific sequences. However, primate-specific candidate elements, particularly those active during fetal brain development and in excitatory neurons and astrocytes, are implicated in the heritability of brain-related human traits. Additionally, we introduce PsychSCREEN, a web-based platform offering interactive visualization of PsychENCODE-generated genetic and epigenetic data from diverse brain cell types in individuals with psychiatric disorders and healthy controls.
- Top Cited Papers
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6698) , eadh0829
Cross-ancestry atlas of gene, isoform, and splicing regulation in the developing human brain
Neuropsychiatric genome-wide association studies (GWASs), including those for autism spectrum disorder and schizophrenia, show strong enrichment for regulatory elements in the developing brain. However, prioritizing risk genes and mechanisms is challenging without a unified regulatory atlas. Across 672 diverse developing human brains, we identified 15,752 genes harboring gene, isoform, and/or splicing quantitative trait loci, mapping 3739 to cellular contexts. Gene expression heritability drops during development, likely reflecting both increasing cellular heterogeneity and the intrinsic properties of neuronal maturation. Isoform-level regulation, particularly in the second trimester, mediated the largest proportion of GWAS heritability. Through colocalization, we prioritized mechanisms for about 60% of GWAS loci across five disorders, exceeding adult brain findings. Finally, we contextualized results within gene and isoform coexpression networks, revealing the comprehensive landscape of transcriptome regulation in development and disease.
- 24 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6698) , eadh0829
Top Cited PapersCross-ancestry atlas of gene, isoform, and splicing regulation in the developing human brain
Neuropsychiatric genome-wide association studies (GWASs), including those for autism spectrum disorder and schizophrenia, show strong enrichment for regulatory elements in the developing brain. However, prioritizing risk genes and mechanisms is challenging without a unified regulatory atlas. Across 672 diverse developing human brains, we identified 15,752 genes harboring gene, isoform, and/or splicing quantitative trait loci, mapping 3739 to cellular contexts. Gene expression heritability drops during development, likely reflecting both increasing cellular heterogeneity and the intrinsic properties of neuronal maturation. Isoform-level regulation, particularly in the second trimester, mediated the largest proportion of GWAS heritability. Through colocalization, we prioritized mechanisms for about 60% of GWAS loci across five disorders, exceeding adult brain findings. Finally, we contextualized results within gene and isoform coexpression networks, revealing the comprehensive landscape of transcriptome regulation in development and disease.
- Open Access
- 29 February 2024
- Published by Springer Nature in Research Square
Trans-Ancestry Analysis of Psychosis Biotypes: Shared Polygenic Risk and Unique Genomic Associations
The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) has categorized psychosis disorders (Schizophrenia, Schizoaffective Disorder and Bipolar Disorder) into three distinct Biotypes, based on neurobiological measurements in a multi-ancestry sample. Two recently developed post hoc ancestry adjustment methods of Polygenic Risk Scores (PRSs) generate Trans-Ancestry PRSs (TAPRSs), which allow for PRS analysis of multi-ancestry samples. Applied to schizophrenia PRS, we found the Khera TAPRS method to show superior portability and comparable prediction accuracy as compared with the Ge method. The three Biotypes of psychosis disorders had similar TAPRSs across ancestries. In genomic analysis of Biotypes, nine genes and isoforms showed significant genomic associations with Biotypes in Transcriptome-Wide Association Study (TWAS) of gene expression in adult brain and fetal brain, and of gene isoforms. TWAS inflation was successfully controlled by inclusion of genotype Principal Components in the association analyses. Biotypes and Biotype-related diagnosis distributions differ between African American and European ancestries.
- 29 February 2024
- Published by Springer Nature in Research Square
Open AccessTrans-Ancestry Analysis of Psychosis Biotypes: Shared Polygenic Risk and Unique Genomic Associations
The Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) has categorized psychosis disorders (Schizophrenia, Schizoaffective Disorder and Bipolar Disorder) into three distinct Biotypes, based on neurobiological measurements in a multi-ancestry sample. Two recently developed post hoc ancestry adjustment methods of Polygenic Risk Scores (PRSs) generate Trans-Ancestry PRSs (TAPRSs), which allow for PRS analysis of multi-ancestry samples. Applied to schizophrenia PRS, we found the Khera TAPRS method to show superior portability and comparable prediction accuracy as compared with the Ge method. The three Biotypes of psychosis disorders had similar TAPRSs across ancestries. In genomic analysis of Biotypes, nine genes and isoforms showed significant genomic associations with Biotypes in Transcriptome-Wide Association Study (TWAS) of gene expression in adult brain and fetal brain, and of gene isoforms. TWAS inflation was successfully controlled by inclusion of genotype Principal Components in the association analyses. Biotypes and Biotype-related diagnosis distributions differ between African American and European ancestries.
- Open Access
Isoform-level transcriptome-wide association uncovers extensive novel genetic risk mechanisms for neuropsychiatric disorders in the human brain
Integrative methods, like colocalization and transcriptome-wide association studies (TWAS), identify transcriptomic mechanisms at only a fraction of trait-associated genetic loci from genome-wide association studies (GWAS). Here, we show that a reliance on reference functional genomics panels of only total gene expression greatly contributes to this reduced discovery. This is particularly relevant for neuropsychiatric traits, as the brain expresses extensive, complex, and unique alternative splicing patterns giving rise to multiple genetically-regulated transcript-isoforms per gene. Integrating highly correlated transcript-isoform expression with GWAS requires methodological innovations. We introduce isoTWAS, a multivariate framework to integrate genetics, isoform-level expression, and phenotypic associations in a step-wise testing framework, and evaluate it using data from the Genotype-Tissue Expression (GTEx) Project, PsychENCODE Consortium, and other sources. isoTWAS shows three main advantages. First, joint, multivariate modeling of isoform expression from cis -window SNPs improves prediction by ∼1.8-2.4 fold, compared to univariate modeling. Second, compared to gene-level TWAS, these improvements in prediction lead to ∼1.9-2.5-fold increase in the number of testable genes and a median of 25-70% increase in cross-validated prediction of total gene expression, with the added ability to jointly capture expression and splicing mechanisms. In external validation, isoform-centric models predicted gene expression at percent variance explained >1% for 50% more genes than gene-centric models. Third, across 15 neuropsychiatric traits, isoTWAS increased discovery of trait associations within GWAS loci over TWAS, capturing ∼60% more unique loci and 95% of loci detected by TWAS. Results from extensive simulations showed no increase in false discovery rate and reinforce isoTWAS’s advantages in prediction and trait mapping power over TWAS, especially when genetic effects on expression vary across isoforms of the same gene. We illustrate multiple biologically-relevant isoTWAS-identified trait associations undetectable by gene-level methods, including isoforms of AKT3 , CUL3 , and HSPD1 with schizophrenia risk, and PCLO with multiple disorders. The isoTWAS framework addresses an unmet need to consider the transcriptome on the transcript-isoform level to increase discovery of trait associations, especially for brain-relevant traits.
Open AccessIsoform-level transcriptome-wide association uncovers extensive novel genetic risk mechanisms for neuropsychiatric disorders in the human brain
Integrative methods, like colocalization and transcriptome-wide association studies (TWAS), identify transcriptomic mechanisms at only a fraction of trait-associated genetic loci from genome-wide association studies (GWAS). Here, we show that a reliance on reference functional genomics panels of only total gene expression greatly contributes to this reduced discovery. This is particularly relevant for neuropsychiatric traits, as the brain expresses extensive, complex, and unique alternative splicing patterns giving rise to multiple genetically-regulated transcript-isoforms per gene. Integrating highly correlated transcript-isoform expression with GWAS requires methodological innovations. We introduce isoTWAS, a multivariate framework to integrate genetics, isoform-level expression, and phenotypic associations in a step-wise testing framework, and evaluate it using data from the Genotype-Tissue Expression (GTEx) Project, PsychENCODE Consortium, and other sources. isoTWAS shows three main advantages. First, joint, multivariate modeling of isoform expression from cis -window SNPs improves prediction by ∼1.8-2.4 fold, compared to univariate modeling. Second, compared to gene-level TWAS, these improvements in prediction lead to ∼1.9-2.5-fold increase in the number of testable genes and a median of 25-70% increase in cross-validated prediction of total gene expression, with the added ability to jointly capture expression and splicing mechanisms. In external validation, isoform-centric models predicted gene expression at percent variance explained >1% for 50% more genes than gene-centric models. Third, across 15 neuropsychiatric traits, isoTWAS increased discovery of trait associations within GWAS loci over TWAS, capturing ∼60% more unique loci and 95% of loci detected by TWAS. Results from extensive simulations showed no increase in false discovery rate and reinforce isoTWAS’s advantages in prediction and trait mapping power over TWAS, especially when genetic effects on expression vary across isoforms of the same gene. We illustrate multiple biologically-relevant isoTWAS-identified trait associations undetectable by gene-level methods, including isoforms of AKT3 , CUL3 , and HSPD1 with schizophrenia risk, and PCLO with multiple disorders. The isoTWAS framework addresses an unmet need to consider the transcriptome on the transcript-isoform level to increase discovery of trait associations, especially for brain-relevant traits.